Rapid communication
The ketogenic diet changes metabolite levels in hippocampal extracellular fluid

https://doi.org/10.1016/j.neuint.2010.10.011Get rights and content

Abstract

Despite successful use of the ketogenic diet (KD) for the treatment of drug-resistant epilepsy, its mechanism of action is unclear. After KD-feeding, increased plasma d-beta-hydroxybutyrate (BHB) levels appear to be important for protection against seizures. We hypothesized that the KD leads to metabolic changes in the brain, which are reflected in the hippocampal extracellular fluid (hECF). CD1 mice were fed control or KD for 2–3 weeks since weaning. In vivo microdialysis of hECF was used to measure the levels of glucose, lactate, as well as BHB under basal conditions and during 30 min stimulation with 60 mM K+, which was retrodialysed. The hECF BHB concentration in KD-fed mice was determined as 43.4 ± 10.1 μM using the zero-flow method and 50.7 ± 5.5 μM based on in vitro recovery. The total BHB concentration in brain homogenate from KD-fed mice was 180 nmol/g. The intracellular BHB concentration is therefore estimated to be about 3-fold higher than the extracellular level, which suggests that BHB in adolescent mouse brains may not be quickly metabolized. The basal hECF glucose concentration was 30% lower in KD-fed mice, indicating that glucose may be less important as an energy source. Lactate levels were similar in control and KD-fed mice. High potassium stimulation elevated lactate by 3–3.5-fold and decreased glucose by 40–50% in both diet groups, consistent with similar anaerobic and aerobic metabolism in both diet groups during high hippocampal activity. Overall, these data (1) defined the BHB concentration in the hippocampal extracellular fluid in KD-fed mice and (2) showed lower glucose metabolism compared to control diet-fed mice. This work will now enable other researchers to mimic the hippocampal extracellular environment in experiments aimed at deciphering the mechanisms of the KD.

Introduction

The ketogenic diet (KD) is a strict high fat, low protein, low carbohydrate diet, and is anticonvulsant in many drug-resistant epileptic children (Freeman et al., 2007, Neal et al., 2009). The KD is also effective in mice as previously reported (Uhlemann and Neims, 1972) and corroborated by us (Samala et al., 2008). The KD leads to the generation of ketone bodies d-β-hydroxybutyrate and acetoacetate) by the liver, reaching plasma levels of BHB in the millimolar range, 1–2 mM in our hands in mice (Samala et al., 2008) or 4 mM in children (Neal et al., 2009). BHB can enter the brain through the monocarboxylate transporters and can then be metabolized in the brain to acetyl-CoA (Nehlig, 2004). Several hypotheses have been proposed about the anticonvulsant mechanism of the KD, including changes in the extracellular milieu (Schwartzkroin, 1999). It was found that ketones directly reduce the spontaneous firing rate of neurons in the substantia nigra pars reticulata and this action was abolished by removal of K(ATP) channels (Ma et al., 2007). Yet, the physiological levels of extracellular ketones in the brain are still unknown. One of the main hypotheses is that the ketogenic diet is anticonvulsant by providing the brain with ketone bodies and thus additional ATP (DeVivo et al., 1978; reviewed by Schwartzkroin, 1999). So far, this hypothesis has been mainly addressed by measuring metabolite and neurotransmitter levels in tissue homogenates or in the cerebrospinal fluid. These measurements have pointed to some metabolic changes in energy and neurotransmitter metabolism (e.g. Bough et al., 2006, DeVivo et al., 1978, Yudkoff et al., 2005). However, total tissue or CSF levels of neurotransmitters and metabolites are not reflective of the neuronal microenvironment, the brain extracellular brain fluid (ECF), which ultimately determines neuronal and astrocytic energy supply and excitability. We showed previously that our 6:1 KD containing the same vitamin, mineral and antioxidant content per caloric density as the control diet, was repeatedly anticonvulsant in the 6 Hz test (Samala et al., 2008). In the present study, we determined the composition of the extracellular fluid in the hippocampus under basal conditions and after stimulation with high potassium levels. We expected to observe a reduced metabolism of glucose in the KD-fed mice, as BHB can be used as an alternative substrate for energy metabolism.

Section snippets

Diets and mice

All experiments were approved by the Institutional Animal Care and Use Committee of Texas Tech University Health Sciences Center and conducted in accordance with its guidelines. Every effort was made to reduce animal suffering. All mice were housed under a 12 h light/dark cycle with free access to food and water. Male CD1 mice (Charles River) were placed onto either a standard diet (TD.06316) or 6.3:1 KD as used by (Samala et al., 2008) immediately after weaning for 2–3 weeks. The amounts of

BHB levels

The microdialysis probe location is shown in Fig. 1A. Two methods were used to determine the extracellular concentration of BHB in the hECF. Using the zero-flow method we measured 43.4 ± 10.1 μM BHB (n = 9; Fig. 1B and C). Using the in vitro recovery of our probes for BHB of 18.2 ± 0.3% at 1 μl/min and the recovered BHB concentration at 1 μl/min, we arrived at 50.7 ± 5.5 μM hECF BHB (n = 8). It remains to be investigated if this low BHB level is sufficient for the inhibition of ATP-dependent potassium

Conflict of interest

The authors declare no conflicts of interest.

Acknowledgements

We thank Sarah Willis for excellent help with some of the experiments. This project was funded by the Epilepsy Foundation (KB).

References (15)

There are more references available in the full text version of this article.

Cited by (28)

  • Neuroketotherapeutics: A modern review of a century-old therapy

    2018, Neurochemistry International
    Citation Excerpt :

    Acetoacetate reversibly inhibits glutamate release in mouse hippocampal slices and cultured rat neurons at high concentrations of 10 mM (Juge et al., 2010). Others have noted this effect may not have physiologic relevance as extracellular levels of β-hydroxybutyrate in the hippocampal microenvironment were determined to be between 40 and 50 μM following three weeks of KD (McNally and Hartman, 2012; Samala et al., 2011). In light of this, the role of ketotherapeutics in modulating neurotransmitter balance remains speculative.

  • Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

    2018, Neuropharmacology
    Citation Excerpt :

    Magnetic resonance spectroscopy (MRS) studies in KD-treated epileptic children and fasted adults have demonstrated that dietary ketosis dramatically increases brain β-hydroxybutyrate, and that brain and plasma concentrations are linearly related with brain β-hydroxybutyrate being approximately 26% of plasma concentrations (Shen et al., 1998; Pan et al., 2000). This is in rough agreement with the relationship found between brain and plasma of KD-fed mice (18%; Samala et al., 2011). However, microdialysis in the hippocampus of KD-fed mice indicate that β-hydroxybutyrate in extracellular fluid is 5% of the plasma concentration.

  • Augmenting brain metabolism to increase macro- and chaperone-mediated autophagy for decreasing neuronal proteotoxicity and aging

    2017, Progress in Neurobiology
    Citation Excerpt :

    An expansion of bioenergetic reserves, elevation in ATP concentration, reduced neuronal glucose concentration, the generation of BDNF (brain derived neurotrophic factor) and the inhibition of mitochondrial permeability transition have been described as underlying metabolic mechanisms (Masino and Rho, 2012). It is intriguing to note that seizure-prone areas such as the hippocampus benefit from an exchange of brain fuel to ketone bodies and result in up to 30% decreased glucose levels in the hippocampal extracellular fluid (Samala et al., 2011). Similar brain regions are known areas of (Bordi et al., 2016) susceptibility for toxic protein aggregation, with early onset of MAPT/tau and amyloid pathology (Braak and Braak, 1991; Braak et al., 1989), supporting the notion of a potentially protective role of ketone bodies in affecting hippocampal protein aggregation.

  • A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study

    2017, Neuroscience Letters
    Citation Excerpt :

    Several hypotheses try to explain the benefit of the KD. For instance, it has been shown to decrease beta-hydroxy-butyrate and glucose extracellular levels in the hippocampus of rats [31]. However, direct neural mechanisms have been elusive.

  • Diet and the Gut Microbiota - How the Gut: Brain Axis Impacts on Autism

    2014, Diet-Microbe Interactions in the Gut: Effects on Human Health and Disease
View all citing articles on Scopus
View full text